tradingkey.logo
tradingkey.logo
Search

Onkure Therapeutics Inc

OKUR
Add to Watchlist
4.125USD
+0.135+3.38%
Close 08-17 16:00ETQuotes delayed by 15 min
166.44MMarket Cap
LossP/E TTM

OKUR Balance Sheet

You can check out the annual or quarterly balance sheets of Onkure Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total equity
Cash, cash equivalents and short-term investments
111.56%176.39M
98.74%192.11M
-46.69%59.05M
-8.27%70.33M
8.74%83.37M
16.69%96.66M
7.57%110.76M
-38.97%76.67M
-46.26%76.67M
-11.68%82.83M
1.77%102.96M
8.21%125.61M
12.48%142.68M
-32.36%93.79M
-31.49%101.17M
-26.41%116.08M
-24.19%126.85M
52.01%138.66M
--147.67M
--157.73M
--167.33M
--91.22M
- Cash and cash equivalents
99.70%166.50M
98.74%192.11M
-46.69%59.05M
15.89%70.33M
131.79%83.37M
374.41%96.66M
300.84%110.76M
417.07%60.69M
296.10%35.97M
-32.97%20.38M
38.67%27.63M
-81.11%11.74M
-92.32%9.08M
-74.90%30.39M
-84.01%19.93M
-50.85%62.13M
-15.75%118.26M
32.75%121.09M
--124.66M
--126.41M
--140.37M
--91.22M
-Short-term investments
--9.88M
----
----
----
----
----
----
-85.97%15.98M
-69.53%40.70M
-1.47%62.46M
-7.28%75.33M
111.09%113.88M
1455.61%133.60M
260.84%63.39M
253.09%81.25M
72.22%53.95M
-68.15%8.59M
--17.57M
--23.01M
--31.32M
--26.96M
----
Prepaid expenses
9.59%1.29M
255.79%5.38M
-20.21%1.79M
261.03%1.20M
-10.49%1.18M
38.37%1.51M
-38.73%2.24M
-89.52%331.00K
-63.88%1.32M
-66.20%1.09M
-29.36%3.66M
-35.79%3.16M
-29.39%3.64M
-20.28%3.23M
-14.58%5.18M
-0.26%4.92M
35.41%5.16M
73.28%4.05M
--6.06M
--4.93M
--3.81M
--2.34M
Other current assets
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total current assets
110.14%177.68M
101.16%197.48M
-46.16%60.84M
-7.11%71.53M
8.41%84.55M
16.97%98.17M
5.98%113.00M
-40.21%77.00M
-46.70%77.99M
-13.49%83.93M
0.25%106.62M
6.42%128.77M
10.84%146.32M
-32.02%97.02M
-30.82%106.35M
-25.62%121.00M
-22.86%132.01M
52.54%142.72M
--153.73M
--162.66M
--171.14M
--93.56M
Non-current assets
Net Fixed Assets
-9.06%1.27M
-49.59%807.00K
-44.01%1.00M
141.48%1.21M
144.25%1.40M
147.07%1.60M
144.88%1.79M
-67.49%499.00K
-65.00%574.00K
-63.37%648.00K
-57.99%733.00K
7.57%1.54M
7.97%1.64M
9.26%1.77M
723.11%1.75M
613.50%1.43M
1687.06%1.52M
1898.77%1.62M
--212.00K
--200.00K
--85.00K
--81.00K
-Fixed Assets
6.02%2.92M
-16.46%2.37M
-15.37%2.47M
--2.56M
--2.76M
--2.84M
241.62%2.91M
----
----
----
-53.82%853.00K
----
----
----
435.36%1.85M
----
----
----
--345.00K
--316.00K
--188.00K
--174.00K
-Accumulated depreciation
21.64%1.65M
26.43%1.56M
30.56%1.46M
--1.36M
--1.35M
--1.24M
832.50%1.12M
----
----
----
17.65%120.00K
----
----
----
-23.31%102.00K
----
----
----
--133.00K
--116.00K
--103.00K
--93.00K
Other non-current assets
245.69%401.00K
271.56%405.00K
150.46%273.00K
-29.25%104.00K
-24.18%116.00K
70.31%109.00K
34.57%109.00K
81.48%147.00K
93.67%153.00K
-20.99%64.00K
-3.57%81.00K
2.53%81.00K
1.28%79.00K
3.85%81.00K
7.69%84.00K
1.28%79.00K
0.00%78.00K
-95.36%78.00K
--78.00K
--78.00K
--78.00K
--1.68M
Total non-current assets
10.41%1.68M
-29.12%1.21M
-32.88%1.28M
102.63%1.31M
108.80%1.52M
140.17%1.71M
133.91%1.90M
-60.02%646.00K
-57.71%727.00K
-61.51%712.00K
-55.49%814.00K
7.30%1.62M
7.64%1.72M
9.02%1.85M
530.69%1.83M
441.73%1.51M
879.75%1.60M
-3.63%1.70M
--290.00K
--278.00K
--163.00K
--1.76M
Total assets
108.38%179.35M
98.93%198.69M
-45.94%62.12M
-6.19%72.83M
9.34%86.07M
18.01%99.88M
6.95%114.91M
-40.45%77.64M
-46.83%78.72M
-14.39%84.64M
-0.69%107.44M
6.44%130.39M
10.80%148.04M
-31.54%98.87M
-29.76%108.18M
-24.82%122.50M
-22.01%133.61M
51.50%144.41M
--154.02M
--162.94M
--171.30M
--95.32M
Liabilities
Current liabilities
-Other payables
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
----
----
--2.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Accrued expenses
-7.55%4.31M
-50.84%2.90M
-43.94%3.94M
505.52%4.39M
388.98%4.66M
226.23%5.89M
-23.04%7.03M
-93.27%725.00K
-91.78%953.00K
-78.27%1.81M
89.12%9.13M
57.13%10.77M
82.06%11.59M
41.26%8.32M
15.48%4.83M
34.81%6.85M
119.40%6.37M
74.48%5.89M
--4.18M
--5.08M
--2.90M
--3.37M
Other current liabilities
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
----
----
--2.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total current liabilities
-12.56%6.64M
63.11%14.33M
-43.77%5.92M
92.33%6.25M
463.58%7.60M
212.19%8.79M
-42.07%10.53M
-76.05%3.25M
-90.19%1.35M
-73.15%2.81M
155.15%18.18M
43.52%13.56M
64.82%13.74M
32.50%10.48M
14.87%7.12M
48.75%9.45M
149.85%8.34M
101.27%7.91M
--6.20M
--6.35M
--3.34M
--3.93M
Non-current liabilities
Long-term debt and lease liabilities
120.97%590.00K
-100.00%0.00
-100.00%0.00
-68.34%120.00K
-45.73%267.00K
-28.99%409.00K
-14.49%549.00K
-53.33%379.00K
-45.15%492.00K
-41.16%576.00K
-39.38%642.00K
-13.89%812.00K
-15.46%897.00K
-13.13%979.00K
--1.06M
--943.00K
--1.06M
--1.13M
--0.00
--0.00
--0.00
--0.00
-Long-term lease liabilities
120.97%590.00K
-100.00%0.00
-100.00%0.00
-68.34%120.00K
-45.73%267.00K
-28.99%409.00K
-14.49%549.00K
-53.33%379.00K
-45.15%492.00K
-41.16%576.00K
-39.38%642.00K
-13.89%812.00K
-15.46%897.00K
-13.13%979.00K
--1.06M
--943.00K
--1.06M
--1.13M
----
----
----
----
Other non-current liabilities
-70.00%12.00K
-70.00%12.00K
--12.00K
--40.00K
400.00%40.00K
471.43%40.00K
----
-100.00%0.00
-99.09%8.00K
-97.84%7.00K
-75.86%7.00K
1519.70%1.07M
1492.73%876.00K
468.42%324.00K
-95.25%29.00K
-82.72%66.00K
-86.81%55.00K
78.13%57.00K
--611.00K
--382.00K
--417.00K
--32.00K
Total non-current liabilities
96.09%602.00K
-97.33%12.00K
-97.81%12.00K
-57.78%160.00K
-38.60%307.00K
-22.98%449.00K
-15.41%549.00K
-79.85%379.00K
-71.80%500.00K
-55.26%583.00K
-40.35%649.00K
86.42%1.88M
58.87%1.77M
10.05%1.30M
78.07%1.09M
164.14%1.01M
167.63%1.12M
3600.00%1.18M
--611.00K
--382.00K
--417.00K
--32.00K
Total liabilities
-8.34%7.25M
55.31%14.34M
-46.45%5.93M
76.65%6.41M
327.71%7.90M
171.83%9.23M
-41.15%11.08M
-76.52%3.63M
-88.09%1.85M
-71.17%3.40M
129.25%18.83M
47.66%15.44M
64.12%15.51M
29.58%11.78M
20.53%8.21M
55.29%10.46M
151.83%9.45M
129.53%9.09M
--6.81M
--6.74M
--3.75M
--3.96M
Shareholders' equity
Common equity
57.78%416.87M
58.35%413.75M
4.59%270.43M
-13.81%267.17M
-14.54%264.21M
-15.21%261.30M
-15.80%258.55M
1.47%309.97M
1.73%309.14M
29.01%308.15M
29.73%307.08M
29.91%305.48M
29.83%303.88M
2.51%238.86M
2.07%236.70M
2.10%235.15M
2.24%234.06M
6648.28%233.02M
--231.91M
--230.31M
--228.93M
--3.45M
Preferred equity
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--45.65M
Retained earnings
-31.56%-244.74M
-34.43%-229.40M
-38.47%-214.24M
14.92%-200.74M
19.90%-186.04M
24.79%-170.65M
29.18%-154.72M
-23.85%-235.95M
-35.57%-232.26M
-49.48%-226.90M
-59.84%-218.47M
-54.79%-190.52M
-55.64%-171.32M
-55.26%-151.79M
-61.32%-136.68M
-66.06%-123.08M
-79.32%-110.08M
-87.40%-97.76M
---84.73M
---74.12M
---61.39M
---52.17M
Capital reserves
57.78%416.86M
58.34%413.75M
4.59%270.42M
-13.81%267.17M
-14.54%264.20M
-15.21%261.30M
-15.80%258.55M
1.47%309.97M
1.73%309.14M
29.01%308.15M
29.73%307.07M
29.91%305.48M
29.83%303.88M
2.51%238.86M
2.07%236.69M
2.10%235.15M
2.24%234.06M
6648.19%233.01M
--231.90M
--230.31M
--228.93M
--3.45M
Gains losses not affecting retained earnings
---13.00K
----
----
----
----
----
----
109.52%2.00K
58.06%-13.00K
-200.00%-12.00K
118.60%8.00K
19.23%-21.00K
-118.45%-31.00K
-81.25%12.00K
-226.47%-43.00K
-252.94%-26.00K
3260.00%168.00K
--64.00K
--34.00K
--17.00K
--5.00K
----
Total equity
120.18%172.11M
103.37%184.35M
-45.89%56.18M
-10.25%66.43M
1.69%78.17M
11.58%90.65M
17.17%103.83M
-35.61%74.02M
-42.00%76.87M
-6.71%81.24M
-11.36%88.61M
2.59%114.94M
6.74%132.53M
-35.64%87.08M
-32.09%99.97M
-28.27%112.05M
-25.90%124.16M
48.12%135.32M
--147.21M
--156.21M
--167.55M
--91.36M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

Which balance sheet metrics matter most when analyzing OKUR stock?

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Onkure Therapeutics Inc Have?

In its most recent quarterly, Onkure Therapeutics Inc had 166.50M in cash and cash equivalents.

How Much Are Onkure Therapeutics Inc's Total Liabilities?

Onkure Therapeutics Inc reported 5.93M in total liabilities as of the latest reported quarter, including 5.92M in current liabilities and 12.00K in non-current liabilities.

What Are Onkure Therapeutics Inc's Total Assets?

As of the latest reported quarter, Onkure Therapeutics Inc's total assets were 62.12M, consisting of 60.84M in current assets and 1.28M in non-current assets.

How Much Shareholders' Equity Does Onkure Therapeutics Inc Have?

Onkure Therapeutics Inc reported 56.18M in total shareholders' equity as of the latest reported quarter.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.